OSAsense, you have once again achieved the ISO 27001 and NEN7510 certifications, confirming our commitment to high quality data security and quality standards in the healthcare sector.

The ISO 27001 certification attests to our robust information security systems, while the NEN7510 certification specifically addresses the healthcare sector, meeting the highest standards for information security and quality management.

These renewed certifications reflect OSAsense's ongoing commitment to protecting health data and maintaining the highest standards in delivering our services. We are proud of this achievement and continue to strive for outstanding data security and quality of care.

Stay tuned for our ongoing efforts to ensure your health and well-being. At OSAsense, we are committed to safety, quality and the best care for you.

In a competition with stiff competition, our own medical director Dr. Rick Pleijhuis captured the title "Healthcare Innovator of the Year 2023" at the Mobile Healthcare Congress, with nearly half of the votes. The award was given for, among other things, his low-threshold and effective approach to measuring sleep apnea using only a watch and finger sensor.

This innovation is based on a smart watch with a special sensor worn on the finger while sleeping. This makes it easier for potential sleep apnea patients to sleep comfortably while the watch collects important data.

What sets OSAsense's solution apart is its practicality. The data collected is used to generate detailed reports, allowing general practitioners to respond quickly and effectively. Whether referring patients to a sleep center or ruling out sleep apnea, Dr. Rick Pleijhuis's innovation provides a useful tool for medical practice.

By winning this award, it underscores the value of Dr. Rick Pleijhuis's contribution to improving healthcare. We congratulate him on this well-deserved recognition and look forward to the continued impact of this practical solution in healthcare.

From July 2023, general practices affiliated with Medrie, regional organization for general practitioners in the Flevoland, Hardenberg and Zwolle regions, can also start using OSAsense.

OSAsense has joined forces with Medrie. Together we are taking an important step forward by jointly offering advanced screening for sleep apnea.

This strategic partnership combines OSAsense's expertise with Medrie's extensive network in the aforementioned regions. As of July 2023, general practices affiliated with Medrie will have the opportunity to use this innovative screening, significantly increasing the accessibility of this important service.

This initiative aims not only to detect sleep apnea at an early stage, but also to provide practical solutions. GP practices will benefit from the implementation of OSAsense technology, enhancing diagnostic capabilities and ensuring an improved care experience for patients.

The joint commitment of OSAsense and Medrie is a clear manifestation of our shared mission to provide high-quality care and innovative solutions to the communities we serve. We look forward to working together to build a healthier future with prevention and accessibility at its core.

Stay tuned to our joint efforts and find out how OSAsense and Medrie are working together to advance the health and well-being of our communities.

This study focuses on improving screening for obstructive sleep apnea (OSA) in atrial fibrillation (AF), due to the under-diagnosed nature of OSA despite strong associations. AF is the most common cardiac arrhythmia worldwide and causes serious complications. The aim is to find an innovative method for more effective OSA identification in AF patients.

In the Netherlands, there were 362,700 people with AF in 2019, with annual increases. Effective AF treatment requires identification of risk factors, including OSA. Untreated OSA predicts AF treatment failure.

Current OSA screening methods, such as questionnaires, prove inadequate according to a problem analysis. A literature review and expert interviews show OSAsense, a pulse oximetry method, as a promising innovation. An implementation pilot showed the cost-effectiveness and patient-friendliness of OSAsense, with fewer unnecessary referrals to sleep clinics.

Experts and patients consider OSAsense the best innovation for OSA screening in AF patients. Further implementation is supported, with emphasis on integrated follow-up and coordination by nurse specialists at outpatient AF and sleep disorders clinics. OSAsense offers a safe, cost-effective and patient-friendly approach, with potential for national expansion to other care pathways and AF outpatient clinics.

Click here for the entire article